Blood from umbilical cords can build new immune systems for adults with leukemia, offering a potentially lifesaving treatment for the many patients who cannot find suitable bone marrow ...
Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ALL patients. Chimeric antigen receptor (CAR) T-cell therapy has shown promise in inducing ...
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the U.S. Food and ...
A new Yale-led study published Thursday identified a new target for treating the most common form of cancer in children and ...
A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...
Acute lymphoblastic leukemia (ALL) manifests as a malignant transformation and proliferation of lymphoid progenitor cells in the bone marrow, blood and eventually extramedullary sites. While mostly ...
A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. This story was originally published on BioPharma Dive. To receive daily news ...
It’s a new application for a cancer medicine that traditionally helps adults. But when it was given to young patients with the most common form of childhood leukemia, it was a game-changer. Every ...
Acute lymphoblastic leukemia (ALL) is known as a pediatric leukemia, with approximately half of cases occurring in children. ALL is the most common childhood malignancy, representing 75% to 80% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback